Tasso and ARUP Laboratories Partner for Innovative Decentralized Clinical Research Solutions
In a groundbreaking development set to revolutionize clinical research, Tasso Inc. and ARUP Laboratories have announced a strategic partnership centered around enhancing decentralized clinical research through advanced blood testing solutions. Tasso, renowned for its innovative patient-centric blood collection technology, is joining forces with ARUP Laboratories, a prominent nonprofit reference laboratory, to create a comprehensive service aimed at facilitating high-quality blood collection and testing in the comfort of patients' homes.
The primary objective of this partnership is to streamline the blood testing process for clinical research, effectively addressing the barriers that have traditionally hindered patient access to these studies. The introduction of remote testing solutions powered by Tasso’s cutting-edge devices will not only simplify blood collection but will also ensure that the quality and reliability of ARUP's exceptional testing capabilities is maintained.
Dr. Erwin Berthier, Chief Technology Officer and co-founder of Tasso, emphasized the significance of patient-centric testing in the pursuit of enhancing clinical research accessibility. He stated, "Patient-centric testing solutions are needed to provide better access to clinical research and enable the development of personalized or predictive blood testing solutions." This partnership is thus poised to advance the paradigm of how clinical studies interact with participants, ensuring that more individuals can engage with research without the need to travel to traditional laboratory settings.
As part of the initial phase of their collaboration, ARUP Laboratories has validated several key tests utilizing Tasso’s blood collection devices. These include important biomarkers: rheumatoid factor (RF), high-sensitivity C-reactive protein (hsCRP), creatinine, and high-sensitivity DNA testing, which all leverage capillary blood microsamples. The promising results from these validations lay the groundwork for further expansion of tests available through this partnership. Additional assays are expected to be developed throughout 2025 as new protocols for validation are completed.
Tasso’s platform offers a comprehensive suite of end-to-end services, including innovative shipping solutions and digital interfaces that will further enhance patient engagement and facilitate the seamless logistics associated with blood collection. Tracy George, M.D., chief scientific officer at ARUP Laboratories, highlighted that this collaboration aligns perfectly with ARUP’s mission to meet the evolving needs of healthcare systems and patients alike. “Advancing diagnostic solutions that better address the needs of health systems and patients is at the core of ARUP's mission. By developing testing compatible with Tasso's game-changing remote blood collection solutions, we will further increase participant access to clinical research,” she noted.
Founded in 1984, ARUP Laboratories operates as a respected leader in laboratory testing and research, offering a robust array of over 3,000 tests and combinations designed to meet the demands of various clinical settings. The laboratory’s expertise, backed by a faculty of medical directors from the University of Utah, supports both test development and validation, ensuring that all testing adheres to the highest standards of quality.
Tasso, established in Seattle, Washington, is redefining blood collection through its user-friendly technology, which promises a simpler, virtually pain-free collection experience. This innovative approach can significantly improve the accessibility of medical testing and facilitate a broader engagement of patients in their healthcare journeys.
As this partnership unfolds, both Tasso and ARUP Laboratories are excited about the potential to reshape how clinical research is conducted, ultimately paving the way for broader patient access and improved health outcomes. The collaboration seeks to convert traditional testing methodologies into a more dynamic and patient-friendly model that prioritizes convenience without sacrificing quality.
In conclusion, this partnership between Tasso and ARUP Laboratories heralds a new era of decentralized clinical research testing — one that balances innovation, accessibility, and excellence in diagnostic solutions.
The primary objective of this partnership is to streamline the blood testing process for clinical research, effectively addressing the barriers that have traditionally hindered patient access to these studies. The introduction of remote testing solutions powered by Tasso’s cutting-edge devices will not only simplify blood collection but will also ensure that the quality and reliability of ARUP's exceptional testing capabilities is maintained.
Dr. Erwin Berthier, Chief Technology Officer and co-founder of Tasso, emphasized the significance of patient-centric testing in the pursuit of enhancing clinical research accessibility. He stated, "Patient-centric testing solutions are needed to provide better access to clinical research and enable the development of personalized or predictive blood testing solutions." This partnership is thus poised to advance the paradigm of how clinical studies interact with participants, ensuring that more individuals can engage with research without the need to travel to traditional laboratory settings.
As part of the initial phase of their collaboration, ARUP Laboratories has validated several key tests utilizing Tasso’s blood collection devices. These include important biomarkers: rheumatoid factor (RF), high-sensitivity C-reactive protein (hsCRP), creatinine, and high-sensitivity DNA testing, which all leverage capillary blood microsamples. The promising results from these validations lay the groundwork for further expansion of tests available through this partnership. Additional assays are expected to be developed throughout 2025 as new protocols for validation are completed.
Tasso’s platform offers a comprehensive suite of end-to-end services, including innovative shipping solutions and digital interfaces that will further enhance patient engagement and facilitate the seamless logistics associated with blood collection. Tracy George, M.D., chief scientific officer at ARUP Laboratories, highlighted that this collaboration aligns perfectly with ARUP’s mission to meet the evolving needs of healthcare systems and patients alike. “Advancing diagnostic solutions that better address the needs of health systems and patients is at the core of ARUP's mission. By developing testing compatible with Tasso's game-changing remote blood collection solutions, we will further increase participant access to clinical research,” she noted.
Founded in 1984, ARUP Laboratories operates as a respected leader in laboratory testing and research, offering a robust array of over 3,000 tests and combinations designed to meet the demands of various clinical settings. The laboratory’s expertise, backed by a faculty of medical directors from the University of Utah, supports both test development and validation, ensuring that all testing adheres to the highest standards of quality.
Tasso, established in Seattle, Washington, is redefining blood collection through its user-friendly technology, which promises a simpler, virtually pain-free collection experience. This innovative approach can significantly improve the accessibility of medical testing and facilitate a broader engagement of patients in their healthcare journeys.
As this partnership unfolds, both Tasso and ARUP Laboratories are excited about the potential to reshape how clinical research is conducted, ultimately paving the way for broader patient access and improved health outcomes. The collaboration seeks to convert traditional testing methodologies into a more dynamic and patient-friendly model that prioritizes convenience without sacrificing quality.
In conclusion, this partnership between Tasso and ARUP Laboratories heralds a new era of decentralized clinical research testing — one that balances innovation, accessibility, and excellence in diagnostic solutions.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.